Clinical trial

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

NCT00761319

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Latanoprost ophthalmic solution 0.005% (XALATAN®) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-10-01

PhasePHASE3

Conditions

Open-angle Glaucomaverified · MONDO: open-angle glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)DRUG

Latanoprost ophthalmic solution 0.005% (XALATAN®)DRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00761319 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.